United States · Investor

Mission Bay Capital

Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

VC firmQuietLast fund $26M, Aug 2018

Pre-seedSeedSeries ALife Science

Cheques on record
0%of best year0cheques in 12 months, 18 on record
Since the last cheque2657days00hrs00min00sec
Median round$33MRounds led0 of 18Sole investor3 roundsMostly inUnited States, 100%
Pitch Mission Bay Capital

Mission Bay Capital highlights

  1. 01

    18 rounds on record

  2. 02

    Mostly Series A and Seed: 59% of its rounds

  3. 03

    Sole investor in 3 rounds, median $4.5M

What they do

Early stage life science venture capital firm.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Pre-seedSeedSeries ASeries B
Sectors
Life Science
Based in
San Francisco, United States
Cold pitches
Not stated

The record

Portfolio map10 startups in 2 sectors, with stats, scatter and world map

Every round we can evidence, newest first18 appearances

  1. 2019

    1 round

  2. Aug
    GlycomineSeries B · US · FinSMEs$33MWith 4 others
  3. 2018

    1 round

  4. Mar
    Wild TypeSeed · US · TechCrunch$3.5MWith 1 other
  5. 2017

    2 rounds

  6. Dec
    PionyrSeries B · US · FinSMEs$62MWith 5 others
  7. Jun
    Vivace TherapeuticsUS · FinSMEs$40MWith 3 others
  8. 2016

    1 round

  9. Dec
    Circle PharmaSeries A · US · FinSMEs$4.5MSole investor
  10. 2015

    4 rounds

  11. Nov
    AtrecaSeries A · US$56MWith 2 others
  12. Sept
    AlectorSeries C · US$32MWith 5 others
  13. Jul
    SiteOne TherapeuticsVenture · US$1.3MWith 3 others
  14. Jun
    Bolt ThreadsSeries B · US$32MWith 5 others
  15. 2014

    4 rounds

  16. Nov
    Bolt ThreadsSeries A · US$7.7MWith 3 others
  17. Sept
    Circle PharmaSeed · USUndisclosedWith 1 other
  18. Sept
    Zephyrus BiosciencesSeed · US$1.5MWith 6 others
  19. Apr
    Principia BioPharmaSeries B · US$50MWith 5 others
  20. 2013

    1 round

  21. May
    Effector TherapeuticsSeries A · US · fiercebiotech.com$45MWith 6 others
  22. 2012

    1 round

  23. Oct
    Principia BioPharmaSeries A · US · bizjournals.com$13MWith 4 others
  24. 2010

    2 rounds

  25. Jul
    Calithera BiosciencesSeries A · US · calithera.com$40MWith 4 others
  26. Apr
    Redwood BioscienceVenture · US · redwoodbioscience.com$300KSole investor
  27. 2009

    1 round

  28. Oct

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

DKDouglas Kingsley CrawfordFund Manager, Member of the General PartneriFiling they signed
RKRegis KellyOfficer and Director of the Managing MemberiFiling they signed
RGRobert Glenn BlazejPrincipal of the General PartneriFiling they signed

We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$157Mgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
Legal name
MBC FII Management, LLC
SEC number
CRD 298755

Who backs their funds

1 LP on record in Mission Bay Capital's funds

Committed
$8.9M
Funds
2
Vintages
2015 to 2018

The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Jun 2025.

What they claim to have backed

From their own portfolio page (on their website)

15 of 21 we have independently watched raise

AlessatherapeuticsAmbagon-therapeuticsApplaudmedicalAsherbioCelldesignlabsChronotheraCirclepharmaDrenbioEpiodyneGlycomineInvenio-imagingKitMammothMitokinineFFECTOR1Alpine-roadsAvexegenCariboubioFluxionbioGraphwearLogic

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Mission Bay Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Mission Bay Capital put money into.

Quick answers about Mission Bay Capital

What does Mission Bay Capital invest in?

Mission Bay Capital invests most often at Series A and Seed (59% of the rounds on record), in sectors such as Life Science.

How active is Mission Bay Capital?

18 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.

What has Mission Bay Capital invested in recently?

Its most recent investments on record: Glycomine (Series B, Aug 2019), Wild Type (Seed, Mar 2018) and Pionyr (Series B, Dec 2017).

How big are Mission Bay Capital's cheques?

The median round it joins is $33M.

Does Mission Bay Capital lead rounds?

Rarely, if at all: none of its 18 investments on record names it as the lead.

Where does Mission Bay Capital invest?

Most of the companies it backs are in the United States (100%).

Is Mission Bay Capital investing now?

No investments in the last 12 months; the latest was in Aug 2019.

Who does Mission Bay Capital invest alongside?

Most often OrbiMed (4 rounds together), Morgenthaler Ventures (3 rounds together) and SR One (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it